02/14/2025
11:37 AM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
7:19 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
6:51 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2025
3:15 PM | Benitec Biopharma (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
11:51 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
01/03/2025
4:39 PM | Benitec Biopharma (Issuer)
Mukadam Sophie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/31/2024
5:34 AM | Benitec Biopharma (Filer)
| Form 8-K/A | |
12/26/2024
3:28 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
5:48 PM | Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:17 PM | Benitec Biopharma (Issuer)
Boston Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BNTC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
12/11/2024
4:19 PM | Banks Jerel A. (Reporting)
Benitec Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:20 PM | Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:22 PM | Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:24 PM | Benitec Biopharma (Issuer)
Francis Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:01 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
12:47 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
12/05/2024
3:36 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:36 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A | |
11/14/2024
3:53 PM | Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
3:32 PM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
11/07/2024
11:30 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
11/06/2024
2:26 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/01/2024
4:04 PM | Benitec Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/25/2024
1:19 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
10/23/2024
8:23 AM | Benitec Biopharma (Filer)
| Form DEF 14A | |
10/22/2024
4:24 PM | Benitec Biopharma (Filer)
| Form DEFA14A | |
10/15/2024
7:07 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
5:08 AM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
4:13 PM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
3:52 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:53 PM | Benitec Biopharma (Filer)
| Form PRE 14A | |
10/08/2024
3:45 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:46 PM | Benitec Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/30/2024
4:17 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:18 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A | |
09/26/2024
3:30 PM | Benitec Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/26/2024
3:43 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:28 PM | Benitec Biopharma (Filer)
| Form DEF 14A | |
07/19/2024
3:59 PM | Benitec Biopharma (Filer)
| Form PRE 14A | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
07/15/2024
4:18 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
9:22 AM | Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
05/13/2024
7:01 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
7:05 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:27 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2024
10:44 AM | Benitec Biopharma (Subject)
Oliveira Steven Michael (Filed by)
| Form SC 13G | |
04/18/2024
8:45 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:53 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
11:10 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Benitec Biopharma (Subject)
| Form SC 13G/A | |
03/08/2024
3:17 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
02/26/2024
8:06 AM | Benitec Biopharma (Filer)
| Form DEL AM | |
